Subscribe To
ACOR / Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript
Content Topics
Acorda
Therapeutics
Inc
ACOR
Cohen
2022
Results
Earnings
Therapeutics
acor
Transcript
Stock
ACOR News
By Business Wire
March 6, 2023
By Seeking Alpha
August 7, 2022
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2022 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (NASDAQ:ACOR ) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Tierney Saccavino - EVP, Corpo more_horizontal
By Benzinga
June 16, 2022
Why Acorda Therapeutics Shares Gaining Today?
Acorda Therapeutics Inc (NASDAQ: ACOR) announced that Esteve Pharmaceuticals GmbH launched INBRIJA 33 mg (levodopa inhalation powder, hard capsule more_horizontal
By Seeking Alpha
May 11, 2022
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript
Start Time: 16:30 January 1, 0000 5:02 PM ET Acorda Therapeutics, Inc. (NASDAQ:ACOR ) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 PM ET Compa more_horizontal
By Seeking Alpha
March 9, 2022
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2021 Results - Earnings Call Transcript more_horizontal